ArticlePublished 18 Dec 2015
Administration of Alpha-1 Antitrypsin in Haemodialysis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The deficit of alpha-1-antitrypsin (AATD) is the most common potentially fatal hereditary disease in adulthood, causing the onset of emphysema, various liver diseases and favouring the development and progression of tumours and systemic vasculitis. Treatment is replacement rate. The dosing schedule alpha1-antitrypsin (α-1AT) has been modified over time by infraestrutura centers dedicated to it. In the beginning, a weekly administration agreed, but given the saturation of the hospitals and the deterioration of the quality of life of patients having to go to hospital every week, it was decided to increase the interval to every 15-21 days.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- BylineArticles whose byline prints “Martin-Gomez MA”
- BylineArticles whose byline prints “Martinez de la Plata E”
- BylineArticles whose byline prints “Hidalgo Rico MA”
- BylineArticles whose byline prints “Palacios Gomez ME”
- BylineArticles whose byline prints “Garcia-Marcos S”